{"id":"W4376273227","doi":"10.1093/oncolo/oyad116","title":"Treatment of Cancer-Associated Thrombosis: Recent Advances, Unmet Needs, and Future Direction","year":2023,"lang":"en","type":"article","venue":"The Oncologist","topic":"Venous Thromboembolism Diagnosis and Management","field":"Medicine","cited_by":36,"is_retracted":false,"has_abstract":true,"ca_institutions":"McMaster University; Thrombosis and Atherosclerosis Research Institute; Ottawa Hospital; University of Ottawa","funders":"National Heart, Lung, and Blood Institute; Swedish Orphan Biovitrum; LEO Pharma; Servier; Chinese Academy of Medical Sciences; KU Leuven; Ministry of Education, Culture, Sports, Science and Technology; Bayer HealthCare; Insmed; ARCA Biopharma; Kowa Company; Prothena; Five Prime Therapeutics; Agios Pharmaceuticals; Ionis Pharmaceuticals; Regeneron Pharmaceuticals; Esperion Therapeutics; Alnylam Pharmaceuticals; Cook Medical; Janssen Scientific Affairs; Japan Agency for Medical Research and Development; Japan Society for the Promotion of Science; GlaxoSmithKline; University of Ottawa; Yale University; Alexion Pharmaceuticals; Daiichi-Sankyo; McMaster University; Brigham and Women's Hospital; Moderna; Pfizer; Heart and Stroke Foundation of Canada; CSL Behring; Eli Lilly and Company; Bristol-Myers Squibb; AstraZeneca; Janssen Pharmaceuticals; Audentes Therapeutics; Amgen; Sanofi; American Heart Association","keywords":"Thrombosis; Intensive care medicine; Cancer; Medicine; Internal medicine","routes":{"ca_aff":true,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.007722183,0.0008032799,0.001721774,0.001417924,0.0006593384,0.003301391,0.001380685,0.004598155,0.0107937],"category_scores_gemma":[0.009229589,0.0003236447,0.001023244,0.001949856,0.001928381,0.006677722,0.001352974,0.005674085,0.002172559],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001680033,"about_ca_system_score_gemma":0.00484032,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001759901,"about_ca_topic_score_gemma":0.005214669,"domain_scores_codex":[0.9977911,0.0007439378,0.0004011141,0.0002494457,0.0005927316,0.0002217362],"domain_scores_gemma":[0.9867522,0.006390842,0.001231075,0.0002644109,0.00366078,0.001700689],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003669049,0.0002588295,0.001053009,0.009303438,0.00013548,0.0002956571,0.0001611821,0.000752999,0.0005460442,0.009481093,0.08669946,0.8909459],"study_design_scores_gemma":[0.000261922,0.0009791601,0.004038215,0.01959895,0.0003964644,0.002046867,0.001534624,0.001912778,0.000423162,0.02437716,0.9443223,0.0001084124],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.000479701,0.9481208,0.0004951526,0.04759344,0.001914885,0.000009041022,0.00003968672,0.0000328215,0.001314459],"genre_scores_gemma":[0.005381827,0.9746115,0.001540823,0.01086607,0.006665512,0.00003016707,0.0001233873,0.00001358334,0.0007670205],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.0107937,"threshold_uncertainty_score":0.04083931,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03496671495848225,"score_gpt":0.3464161656841737,"score_spread":0.3114494507256915,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}